Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2010-02-26

Original market date: See footnote 1

2005-03-02

Product name:

FERRLECIT

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02243333

Product Monograph/Veterinary Labelling:

Date: 2016-12-20 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

SANOFI-AVENTIS CANADA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada  H7V 0A3

Class: 

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription  

American Hospital Formulary Service (AHFS): See footnote 3

20:04.04   IRON PREPARATIONS

Anatomical Therapeutic Chemical (ATC): See footnote 4

B03AC  IRON, PARENTERAL PREPARATIONS

Active ingredient group (AIG) number:See footnote 5

0108536035

List of active ingredient(s)
Active ingredient(s) Strength
IRON (SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION) 12.5 MG / ML

Application information

Related information

Contact us

Date modified: